Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chad V Pecot

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Molecular Systems Biology|December 15, 2015
A genome-scale screen reveals context-dependent ovarian cancer sensitivity to miRNA overexpressionBenjamin B Shields, Chad V Pecot, Hua Gao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2012
Metronomic activity of CD44-targeted hyaluronic acid-paclitaxel in ovarian carcinomaSun Joo Lee, Sukhen C Ghosh, Hee Dong Han, et al.
Lung Cancer (Amsterdam, Netherlands)|January 19, 2021
RNA splicing and aggregate gene expression differences in lung squamous cell carcinoma between patients of West African and European ancestryApril E Deveaux, Tyler A Allen, Muthana Al Abo, et al.
Nature Communications|October 30, 2014
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICERTwan van den Beucken, Elizabeth Koch, Kenneth Chu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2014
Cross-talk between EphA2 and BRaf/CRaf is a key determinant of response to DasatinibJie Huang, Wei Hu, Justin Bottsford-Miller, et al.
JCI Insight|May 6, 2025
Tumor suppressors in Sox2-mediated lung cancers promote distinct cell intrinsic and immunologic remodelingNisitha Sengottuvel, Kristina M Whately, Jennifer L Modliszewski, et al.
Cancer Research Communications|September 23, 2022
Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck CancerRyan M Murphy, Jason Tasoulas, Alessandro Porrello, et al.
Molecular Cancer Therapeutics|October 5, 2014
Therapeutic silencing of KRAS using systemically delivered siRNAsChad V Pecot, Sherry Y Wu, Seth Bellister, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2013
Targeting SRC and tubulin in mucinous ovarian carcinomaTao Liu, Wei Hu, Heather J Dalton, et al.
Cancer Discovery|December 20, 2011
A novel platform for detection of CK+ and CK- CTCsChad V Pecot, Farideh Z Bischoff, Julie Ann Mayer, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Molecular Systems Biology|December 15, 2015
A genome-scale screen reveals context-dependent ovarian cancer sensitivity to miRNA overexpressionBenjamin B Shields, Chad V Pecot, Hua Gao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2012
Metronomic activity of CD44-targeted hyaluronic acid-paclitaxel in ovarian carcinomaSun Joo Lee, Sukhen C Ghosh, Hee Dong Han, et al.
Lung Cancer (Amsterdam, Netherlands)|January 19, 2021
RNA splicing and aggregate gene expression differences in lung squamous cell carcinoma between patients of West African and European ancestryApril E Deveaux, Tyler A Allen, Muthana Al Abo, et al.
Nature Communications|October 30, 2014
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICERTwan van den Beucken, Elizabeth Koch, Kenneth Chu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2014
Cross-talk between EphA2 and BRaf/CRaf is a key determinant of response to DasatinibJie Huang, Wei Hu, Justin Bottsford-Miller, et al.
JCI Insight|May 6, 2025
Tumor suppressors in Sox2-mediated lung cancers promote distinct cell intrinsic and immunologic remodelingNisitha Sengottuvel, Kristina M Whately, Jennifer L Modliszewski, et al.
Cancer Research Communications|September 23, 2022
Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck CancerRyan M Murphy, Jason Tasoulas, Alessandro Porrello, et al.
Molecular Cancer Therapeutics|October 5, 2014
Therapeutic silencing of KRAS using systemically delivered siRNAsChad V Pecot, Sherry Y Wu, Seth Bellister, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2013
Targeting SRC and tubulin in mucinous ovarian carcinomaTao Liu, Wei Hu, Heather J Dalton, et al.
Cancer Discovery|December 20, 2011
A novel platform for detection of CK+ and CK- CTCsChad V Pecot, Farideh Z Bischoff, Julie Ann Mayer, et al.
Pageof 8